hypercapnia
BehavioralTidal volume (6 ml/kg) and respiratory rate is adjusted to achieve the objective values of ETCO2 45mmHg
Other names: ETCO2-45
NCT Number: NCT02643030
The purpose of this study is to evaluate the effects of hypercapnia on hemodynamics and cerebral oxygenation during shoulder arthroscopy.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
The patients are randomly allocated to receive normocapnia or hypercapnia . After the 70º sitting position, record the mean arterial pressure (MAP), heart rate, and regional oxygen saturation (rSO2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tidal volume (6 ml/kg) and respiratory rate is adjusted to achieve the objective values of ETCO2 45mmHg
Other names: ETCO2-45
Tidal volume (10 ml/kg) and respiratory rate is adjusted to achieve the objective values of ETCO2 35mmHg
Other names: ETCO2-35
Time frame: Change from Regional cerebral oxygen saturation at 2,4,6,8,10,20 min after anesthetic induction and sitting position
Gachon University Gil Medical Center
Other
The Effect of Hypercapnia on Regional Cerebral Oxygen Saturation in the Sitting Position
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05053932
Anemia, Anemia, Hemolytic
Paris, IDF, France
View Trial DetailsNCT04046484
Acute Stroke, Brain Diseases
Gurgaon, India
View Trial DetailsNCT04437862
Acute Stroke, Brain Diseases
Tampa, Florida, United States
View Trial DetailsNCT02541591
Brain Diseases, Brain Ischemia
Genk, Belgium
View Trial Details